Get started
Author

Luyao Zhang

Observed name: Zhang, Luyao
Observed institutions: Shenyang Agricultural University, Sun Yat-sen University, Jiangsu Ocean University, Suzhou Municipal Hospital, Nanjing First Hospital, Nanjing Medical University
ORCID: 0009-0002-1684-4569
Observed ORCID: 0009-0002-1684-4569
OpenAlex ID: A5048357228
Targeting the Metabolic Enzyme PGAM2 Overcomes Enzalutamide Resistance in Castration-Resistant Prostate Cancer by Inhibiting BCL2 Signaling
2023 · Zhen Li, Kang Ning, et al. · Cancer Research · 30
Imaging-based adipose biomarkers for predicting clinical outcomes of cancer patients treated with immune checkpoint inhibitors: a systematic review
2023 · Xinyu Pei, Ye Xie, et al. · Frontiers in Oncology · 13
PDF
LncRNA SNHG15 acts as a ceRNA to promote breast cancer progression through the miR-153-3p/KLF5 signal axis
2025 · Xu Zheng, Luyao Zhang, et al. · Journal of Cancer · 1
PDF
Heterogeneity of cancer-associated fibroblasts in tumor metastasis: mechanisms and precision therapeutic strategies
2026 · Yue Li, Yuhan Chen, et al. · Molecular Cancer
WXJ-114, A New CDK4/6 Inhibitor that Treats Breast Cancer by Blocking Cell Cycles
2025 · Jing Ji, Jiaojiao Zhou, et al. · Pharmaceutical Chemistry Journal
[Research progress in mastoparans].
2024 · Anqi Huang, Yinfeng Liang, et al. · PubMed
Data from Targeting the Metabolic Enzyme PGAM2 Overcomes Enzalutamide Resistance in Castration-Resistant Prostate Cancer by Inhibiting BCL2 Signaling
2023 · Zhen Li, Kang Ning, et al.
Supplementary Figures from Targeting the Metabolic Enzyme PGAM2 Overcomes Enzalutamide Resistance in Castration-Resistant Prostate Cancer by Inhibiting BCL2 Signaling
2023 · Zhen Li, Kang Ning, et al.
Supplementary Tables from Targeting the Metabolic Enzyme PGAM2 Overcomes Enzalutamide Resistance in Castration-Resistant Prostate Cancer by Inhibiting BCL2 Signaling
2023 · Zhen Li, Kang Ning, et al.
Data from Targeting the Metabolic Enzyme PGAM2 Overcomes Enzalutamide Resistance in Castration-Resistant Prostate Cancer by Inhibiting BCL2 Signaling
2023 · Zhen Li, Kang Ning, et al.
Supplementary Figures from Targeting the Metabolic Enzyme PGAM2 Overcomes Enzalutamide Resistance in Castration-Resistant Prostate Cancer by Inhibiting BCL2 Signaling
2023 · Zhen Li, Kang Ning, et al.
Works count: 12
Citation count: 44
H-index: 2
I10-index: 2
Year
Topic
Type